172 related articles for article (PubMed ID: 32373964)
1. LncRNA AWPPH accelerates the progression of non-small cell lung cancer by sponging miRNA-204 to upregulate CDK6.
Wu D; Qin BY; Qi XG; Hong LL; Zhong HB; Huang JY
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4281-4287. PubMed ID: 32373964
[TBL] [Abstract][Full Text] [Related]
2. LncRNA CASC19 promotes the proliferation, migration and invasion of non-small cell lung carcinoma via regulating miRNA-130b-3p.
Qu CX; Shi XC; Zai LQ; Bi H; Yang Q
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):247-255. PubMed ID: 31389608
[TBL] [Abstract][Full Text] [Related]
3. lncRNA Colorectal Neoplasia Differentially Expressed (CRNDE) Promotes Proliferation and Inhibits Apoptosis in Non-Small Cell Lung Cancer Cells by Regulating the miR-641/CDK6 Axis.
Fan YF; Yu ZP; Cui XY
Med Sci Monit; 2019 Apr; 25():2745-2755. PubMed ID: 30982057
[TBL] [Abstract][Full Text] [Related]
4. LncRNA HANR aggravates the progression of non-small cell lung cancer via mediating miRNA-140-5p.
Li SJ; Wu YX; Liang YH; Gao Y; Wu AB; Zheng HY; Yang ZX
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):704-711. PubMed ID: 32016972
[TBL] [Abstract][Full Text] [Related]
5. MiRNA-200a-3p suppresses the proliferation, migration and invasion of non-small cell lung cancer through targeting IRS2.
Tan T; Xu XH; Lu XH; Wang XW
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):712-720. PubMed ID: 32016973
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MEG8 promotes tumor progression of non-small cell lung cancer via regulating miR-107/CDK6 axis.
Liu Y; Li L; Shang P; Song X
Anticancer Drugs; 2020 Nov; 31(10):1065-1073. PubMed ID: 32649368
[TBL] [Abstract][Full Text] [Related]
7. lncRNA HNF1A-AS1 modulates non-small cell lung cancer progression by targeting miR-149-5p/Cdk6.
Liu L; Chen Y; Li Q; Duan P
J Cell Biochem; 2019 Nov; 120(11):18736-18750. PubMed ID: 31243821
[TBL] [Abstract][Full Text] [Related]
8. LncRNA HOST2 enhances gefitinib-resistance in non-small cell lung cancer by down-regulating miRNA-621.
Chen ZY; Liu HY; Jiang N; Yuan JM
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9939-9946. PubMed ID: 31799663
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MAGI2-AS3 suppresses the proliferation and invasion of non-small cell lung carcinoma through miRNA-23a-3p/PTEN axis.
Hao XZ; Yang K
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7399-7407. PubMed ID: 31539127
[TBL] [Abstract][Full Text] [Related]
10. LncRNA SNHG12 accelerates the progression of ovarian cancer via absorbing miRNA-129 to upregulate SOX4.
Sun D; Fan XH
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2345-2352. PubMed ID: 30964158
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA MALAT1 regulates proliferation, apoptosis, migration and invasion via miR-374b-5p/SRSF7 axis in non-small cell lung cancer.
Song J; Su ZZ; Shen QM
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1853-1862. PubMed ID: 32141554
[TBL] [Abstract][Full Text] [Related]
12. MiRNA-20a-5p accelerates the proliferation and invasion of non-small cell lung cancer by targeting and downregulating KLF9.
Fang QY; Deng QF; Luo J; Zhou CC
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2548-2556. PubMed ID: 32196605
[TBL] [Abstract][Full Text] [Related]
13. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
[TBL] [Abstract][Full Text] [Related]
14. LncRNA SND1-IT1 accelerates the proliferation and migration of osteosarcoma via sponging miRNA-665 to upregulate POU2F1.
Jin XM; Xu B; Zhang Y; Liu SY; Shao J; Wu L; Tang JA; Yin T; Fan XB; Yang TY
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9772-9780. PubMed ID: 31799644
[TBL] [Abstract][Full Text] [Related]
15. LINC00511 promotes the progression of non-small cell lung cancer through downregulating LATS2 and KLF2 by binding to EZH2 and LSD1.
Zhu FY; Zhang SR; Wang LH; Wu WD; Zhao H
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8377-8390. PubMed ID: 31646568
[TBL] [Abstract][Full Text] [Related]
16. LncRNA PAPAS aggravates the progression of gastric cancer through regulating miRNA-188-5p.
Shi X; You X; Zeng WC; Deng YJ; Hong HL; Huang OX; Wang MF
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10761-10768. PubMed ID: 31858543
[TBL] [Abstract][Full Text] [Related]
17. MiR-587 acts as an oncogene in non-small-cell lung carcinoma via reducing CYLD expression.
Li XJ; Chen LW; Gao P; Jia YJ
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12741-12747. PubMed ID: 33378022
[TBL] [Abstract][Full Text] [Related]
18. Long Non-Coding RNA AWPPH Promotes Postoperative Distant Recurrence in Resected Non-Small Cell Lung Cancer by Upregulating Transforming Growth Factor beta 1 (TGF-β1).
Tang L; Wang T; Zhang Y; Zhang J; Zhao H; Wang H; Wu Y; Liu K
Med Sci Monit; 2019 Apr; 25():2535-2541. PubMed ID: 30953582
[TBL] [Abstract][Full Text] [Related]
19. MiRNA-300 suppresses proliferation, migration and invasion of non-small cell lung cancer via targeting ETS1.
Yang YB; Tan H; Wang Q
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10827-10834. PubMed ID: 31858551
[TBL] [Abstract][Full Text] [Related]
20. Circ0021205 aggravates the progression of non-small cell lung cancer by targeting miRNA-16-5p/VEGFA.
Yang Y; Huang XJ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):213-221. PubMed ID: 31957834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
